Skip to content
Clinical Trials – home

diabetes-falkensee.de – Schwerpunktpraxis für Diabetes, Gefäß- und Ernährungsmedizin

Research site

Germany Poststraße 48-50, 14612 Falkensee, Germany

  • Obesity · Overweight · Type 2 diabetes mellitus
  • Adult patients

About Specializations

diabetes-falkensee.de – Schwerpunktpraxis für Diabetes, Gefäß- und Ernährungsmedizin in Falkensee, Germany specialises in clinical trials of conditions such as Obesity, Overweight, Type 2 diabetes mellitus, and other specialisations. This site conducts important research.

Main research areas of the site

Nutritional and Metabolic Diseases Research

The Zentrum fuer klinische Forschung at the diabetes‑falkensee.de practice focuses on nutritional and metabolic diseases, primarily investigating Type 2 Diabetes Mellitus and chronic weight management. Current studies aim to test new therapies that improve glycemic control and promote safe, effective body weight reduction.

  • Glycemic control improvement
  • Weight reduction strategies
  • Oral anti‑diabetic agents
  • GLP‑1 receptor agonists

With two active investigators and a total of two trials, the site in Falkensee, Germany, provides patients an opportunity to contribute to advancing treatment options in metabolic health.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Poststraße 48-5014612 FalkenseeGermany
Recruiting now
no trials
Conditions studied
3

More sites in FalkenseeGermany

All trials

Ongoing trials

Clinical trials registered at this site – none is enrolling right now.

Condition
Type of trial
Recruitment status
Quick filters

2 clinical trials

Obesity+1

Not recruiting

Study on the Effectiveness and Safety of Maridebart Cafraglutide for Adults with Obesity or Overweight Without Type 2 Diabetes

Investigational
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Maridebart Cafraglutide
  • Sponsor:Amgen Inc.

Study on the Effects of AZD5004 and Semaglutide for Adults with Type 2 Diabetes

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Get verified: confirm your contact details and recruitment status with us, appear first on the pages of your trials and receive patient requests directly.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.